Aicardi Goutières Syndrome Not Yet Recruiting Phase 1 / 2 Trials for Emtricitabine (DB00879)

IndicationStatusPhase
DBCOND0091956 (Aicardi Goutières Syndrome)Not Yet Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03304717Reverse Transcriptase Inhibitors in Aicardi Goutières SyndromeTreatment